Search - tctmd.com

Displaying 101 - 120 of 145

Sort: Relevancy | Date

News Daily News

Bivalirudin’s Bleeding Benefits Dampened by PCI Advances, Analysis Shows

Todd Neale

December 14, 2015

News Conference News AHA 2015

Most Drug Discontinuations in PEGASUS-TIMI 54 Related to Dyspnea, Bleeding

Todd Neale

November 10, 2015

News Conference News TCT 2015

TUXEDO-India Affirms Superiority of EES in Patients With Diabetes

Todd Neale

October 14, 2015

News Conference News TCT 2015

Experts Debate Optimal Pharmacologic Approach for STEMI Patients

October 11, 2015

News Conference News ESC 2015

ESC Congress 2015: Presentations Sift Clinical Wheat From Chaff

September 09, 2015

News Industry News

US FDA Approves Expanded Indication For Brilinta To Include Long-term Use In Patients With a History of Heart Attack

September 03, 2015

News Conference News ESC 2015

Prehospital Administration of Ticagrelor Cuts Early Ischemic Events in STEMI Patients

L.A. McKeown

September 01, 2015

News Daily News

登记研究表明 Absorb BVS 治疗所有糖尿病患者的效果与 DES 相当

August 27, 2015

News Daily News

Un Estudio de Registro Sugiere que AVB y SLF son Iguales en Pacientes Diabéticos No Seleccionados

August 27, 2015

News Daily News

Registry Study Suggests Absorb BVS Matches DES in Diabetic All-Comers

August 27, 2015

News Daily News

替卡格雷预治疗有助于预防 NSTE-ACS 围手术期心肌坏死

June 04, 2015

News Daily News

Ticagrelor Pretreatment May Help Protect Against Periprocedural Myonecrosis in NSTE-ACS

June 04, 2015

News Daily News

El Pretratamiento con Ticagrelor podría No Proteger frente a la Mionecrosis Perioperatoria en el Manejo de cuadros de SCASEST

June 04, 2015

News Daily News

替卡格雷比氯吡格雷更快地抑制接受临时PCI的低风险ACS患者的血小板活性

Todd Neale

May 11, 2015

News Daily News

Ticagrelor Suprime Más Rápidamente la Inhibición Plaquetaria que Clopidogrel en Pacientes SCA de Riesgo Bajo durante la realización de PCI Ad Hoc

Todd Neale

May 11, 2015

News Daily News

Ticagrelor More Rapidly Suppresses Platelet Activity Than Clopidogrel for Low-Risk ACS Patients During Ad Hoc PCI

Todd Neale

May 11, 2015

News Industry News

Antiplatelet Drug Ticagrelor More Effective Than Clopidogrel for Ad Hoc PCI Patients

May 07, 2015

News Daily News

双联抗血小板治疗与高危PAD患者的更佳结果有联系

Leah Lawrence

April 29, 2015

News Daily News

El Tratamiento Antiplaquetario Doble se asoció a Mejores Resultados en Pacientes EAP de Alto Riesgo

Leah Lawrence

April 29, 2015

News Daily News

Dual Antiplatelet Therapy Tied to Better Outcomes in High Risk PAD Patients

Leah Lawrence

April 29, 2015

Advertisement

Bivalirudin’s Bleeding Benefits Dampened by PCI Advances, Analysis Shows

Most Drug Discontinuations in PEGASUS-TIMI 54 Related to Dyspnea, Bleeding

TUXEDO-India Affirms Superiority of EES in Patients With Diabetes

Experts Debate Optimal Pharmacologic Approach for STEMI Patients

ESC Congress 2015: Presentations Sift Clinical Wheat From Chaff

US FDA Approves Expanded Indication For Brilinta To Include Long-term Use In Patients With a History of Heart Attack

Prehospital Administration of Ticagrelor Cuts Early Ischemic Events in STEMI Patients

登记研究表明 Absorb BVS 治疗所有糖尿病患者的效果与 DES 相当

Un Estudio de Registro Sugiere que AVB y SLF son Iguales en Pacientes Diabéticos No Seleccionados

Registry Study Suggests Absorb BVS Matches DES in Diabetic All-Comers

替卡格雷预治疗有助于预防 NSTE-ACS 围手术期心肌坏死

Ticagrelor Pretreatment May Help Protect Against Periprocedural Myonecrosis in NSTE-ACS

El Pretratamiento con Ticagrelor podría No Proteger frente a la Mionecrosis Perioperatoria en el Manejo de cuadros de SCASEST

替卡格雷比氯吡格雷更快地抑制接受临时PCI的低风险ACS患者的血小板活性

Ticagrelor Suprime Más Rápidamente la Inhibición Plaquetaria que Clopidogrel en Pacientes SCA de Riesgo Bajo durante la realización de PCI Ad Hoc

Ticagrelor More Rapidly Suppresses Platelet Activity Than Clopidogrel for Low-Risk ACS Patients During Ad Hoc PCI

Antiplatelet Drug Ticagrelor More Effective Than Clopidogrel for Ad Hoc PCI Patients

双联抗血小板治疗与高危PAD患者的更佳结果有联系

El Tratamiento Antiplaquetario Doble se asoció a Mejores Resultados en Pacientes EAP de Alto Riesgo

Dual Antiplatelet Therapy Tied to Better Outcomes in High Risk PAD Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content